Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 735835, 12 pages
http://dx.doi.org/10.1155/2013/735835
Research Article

Suppression of Osteopontin Functions by Levocetirizine, a Histamine Receptor Antagonist, In Vitro

1Department of Otorhinolaryngology, School of Medicine, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
2Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama 226-8555, Japan

Received 25 September 2013; Revised 27 November 2013; Accepted 27 November 2013

Academic Editor: Hiroto Matsuse

Copyright © 2013 Toshimitsu Komatsuzaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Rittling and D. T. Denhardt, “Osteopontin function in pathology: lessons from osteopontin-deficient mice,” Experimental Nephrology, vol. 7, no. 2, pp. 103–113, 1999. View at Google Scholar · View at Scopus
  2. F. P. Reinholt, K. Hultenby, A. Oldberg, and D. Heinegård, “Osteopontin—a possible anchor of osteoclasts to bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 12, pp. 4473–4475, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Shapses, M. Cifuentes, L. Spevak et al., “Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency,” Calcified Tissue International, vol. 73, no. 1, pp. 86–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Xu, H. Nie, N. Li et al., “Role of osteopontin in amplification and perpetuation of rheumatoid synovitis,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 1060–1067, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. O'Regan, G. L. Chupp, J. A. Lowry, M. Goetschkes, N. Mulligan, and J. S. Berman, “Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro,” Journal of Immunology, vol. 162, no. 2, pp. 1024–1031, 1999. View at Google Scholar · View at Scopus
  6. M. Comabella, I. Pericot, R. Goertsches et al., “Plasma osteopontin levels in multiple sclerosis,” Journal of Neuroimmunology, vol. 158, no. 1-2, pp. 231–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Xanthou, T. Alissafi, M. Semitekolou et al., “Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets,” Nature Medicine, vol. 13, no. 5, pp. 570–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Takahashi, M. Kurokawa, S. Konno et al., “Osteopontin is involved in migration of eosinophils in asthma,” Clinical and Experimental Allergy, vol. 39, no. 8, pp. 1152–1159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Nagasaka, H. Matsue, H. Matsushima et al., “Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells,” European Journal of Immunology, vol. 38, no. 2, pp. 489–499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kurokawa, S. Konno, A. Takahashi et al., “Regulatory role of DC-derived osteopontin in systemic allergen sensitization,” European Journal of Immunology, vol. 39, no. 12, pp. 3323–3330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. H. Howarth, “The cellular basis of allergic rhinitis,” Allergy, vol. 55, pp. 7–16, 2005. View at Google Scholar
  12. T. Nogaki, K. Asano, A. Furuta et al., “Enhancement of clara cell 10-kD protein (CC10) production from nasal epithelial cells by fexofenadine hydrochloride,” Asian Pacific Journal of Allergy and Immunology, vol. 30, no. 2, pp. 139–145, 2012. View at Google Scholar
  13. M. Kurokawa, S. Konno, S. Matsukura et al., “Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma,” International Archives of Allergy and Immunology, vol. 149, no. 1, pp. 7–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. F. Lee, H. L. Sun, K. H. Lu, M. S. Ku, and K. Lue, “The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis,” Pediatric Allergy and Immunology, vol. 20, no. 5, pp. 493–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. B. Tzanetos, J. M. Fahrenholz, T. Scott, and K. Buchholz, “Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial,” Annals of Allergy, Asthma and Immunology, vol. 107, no. 6, pp. 517–522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Gillard, M. S. Benedetti, P. Chatelain, and E. Baltes, “Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines,” Inflammation Research, vol. 54, no. 9, pp. 367–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Asano, K. Kanai, and H. Suzaki, “Suppressive activity of fexofenadine hydrochloride on the production of eosinophil chemoattractants from human nasal fibroblasts in vitro,” Arzneimittel-Forschung, vol. 54, no. 8, pp. 436–443, 2004. View at Google Scholar · View at Scopus
  18. M. Levula, O. Jaakkola, M. Luomala, S. T. Nikkari, and T. Lehtimäki, “Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 66, no. 6, pp. 497–508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Puxeddu, N. Berkman, D. Ribatti et al., “Osteopontin is expressed and functional in human eosinophils,” Allergy, vol. 65, no. 2, pp. 168–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Uchio, N. Matsuura, K. Kadonosono, S. Ohno, and T. Uede, “Tear osteopontin levels in patients with allergic conjunctival diseases,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 240, no. 11, pp. 924–928, 2002. View at Google Scholar · View at Scopus
  21. Y. Liu, X. Lu, H. J. Yu et al., “The expression of osteopontin and its association with Clara cell 10 kDa protein in allergic rhinitis,” Clinical and Experimental Allergy, vol. 40, no. 11, pp. 1632–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Konno, M. Kurokawa, T. Uede, M. Nishimura, and S. Huang, “Role of osteopontin, a multifunctional protein, in allergy and asthma,” Clinical and Experimental Allergy, vol. 41, no. 10, pp. 1360–1366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. H. Howarth, “The cellular basis for allergic rhinitis,” Allergy, vol. 50, no. 23, pp. 6–10, 1995. View at Google Scholar · View at Scopus
  24. M. Kohan, R. Bader, I. Puxeddu, F. Levi-Schaffer, R. Breuer, and N. Berkman, “Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling,” Clinical and Experimental Allergy, vol. 37, no. 10, pp. 1444–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Schoepke, M. K. Church, and M. Maurer, “The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers,” Acta Dermato-Venereologica, vol. 93, no. 3, pp. 286–293, 2013. View at Publisher · View at Google Scholar
  26. I. Sadowska-Woda, E. Bieszczad-Bedrejczuk, and M. Rachel, “Influence of desloratadine on selected oxidative stress markers in patients between 3 and 10 years of age with allergic perennial rhinitis,” European Journal of Pharmacology, vol. 640, no. 1–3, pp. 197–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. T. Denhardt, M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman, “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival,” Journal of Clinical Investigation, vol. 107, no. 9, pp. 1055–1061, 2001. View at Google Scholar · View at Scopus
  28. Y. C. Su, M. S. Rolph, N. G. Hansbro, C. R. Mackay, and W. A. Sewell, “Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation,” Journal of Immunology, vol. 180, no. 4, pp. 2600–2607, 2008. View at Google Scholar · View at Scopus
  29. S. Saha, C. Doe, V. Mistry et al., “Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD,” Thorax, vol. 64, no. 8, pp. 671–676, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Blease, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel, “Chemokines and their role in airway hyper-reactivity,” Respiratory Research, vol. 1, no. 1, pp. 54–61, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Conroy and T. J. Williams, “Eotaxin and the attraction of eosinophils to the asthmatic lung,” Respiratory Research, vol. 2, no. 3, pp. 150–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Hamid, M. K. Tulic', M. C. Liu, and R. Moqbel, “Inflammatory cells in asthma: mechanisms and implications for therapy,” Journal of Allergy and Clinical Immunology, vol. 111, no. 1, supplement, pp. S5–S17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bulfone-Paus and R. Paus, “Osteopontin as a new player in mast cell biology,” European Journal of Immunology, vol. 38, no. 2, pp. 338–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Kanai, K. Asano, S. Watanabe, Y. Kyo, and H. Suzaki, “Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro,” International Archives of Allergy and Immunology, vol. 140, no. 1, pp. 43–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Shoji, K. Asano, A. Furuta, K. Hirano, and H. Suzaki, “Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro,” International Archives of Allergy and Immunology, vol. 155, no. 1, pp. 38–51, 2011. View at Publisher · View at Google Scholar · View at Scopus